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Kv7.2 channel expression has been reported to decrease in dorsal root ganglia (DRG)
following the induction of a peripheral neuropathy while other experiments show
that Kv7.2 accumulates in peripheral neuromas. The mechanisms underlying these
novel expression patterns are poorly understood. Here we use immunofluorescence
methods to analyze Kv7.2 protein expression changes in sensory neurons following
peripheral axotomy and the potential role of axonal transport. Results indicate that
DRG neurons express Kv7.2 in ∼16% of neurons and that this number decreases by
about 65% after axotomy. Damaged neurons were identified in DRG by application
of the tracer Fluoro-ruby at the site of injury during surgery. Reduction of Kv7.2
expression was particularly strong in damaged neurons although some loss was
also found in putative uninjured neurons. In parallel to the decrease in the soma
of axotomized sensory neurons, Kv7.2 accumulated at neuromatose fiber endings.
Blockade of axonal transport with either vinblastine (VLB) or colchicine (COL) abolished
Kv7.2 redistribution in neuropathic animals. Channel distribution rearrangements did
not occur following induction of inflammation in the hind paw. Behavioral tests
indicate that protein rearrangements within sensory afferents are essential to the
development of allodynia under neuropathic conditions. These results suggest that
axotomy enhances axonal transport in injured sensory neurons, leading to a decrease
of somatic expression of Kv7.2 protein and a concomitant accumulation in damaged
fiber endings. Localized changes in channel expression patterns under pathological
conditions may create novel opportunities for Kv7.2 channel openers to act as
analgesics.
Keywords: potassium channels, dorsal root ganglia, axonal endings, spared nerve injury, axotomy, axonal
transport, vinblastine, colchicine
INTRODUCTION
Kv7 (KCNQ) channels are a family of five voltage-gated K+ channel subunits (Kv7.1-Kv7.5) that
yield the M-currents, crucial for controlling homeostasis to the point that mutations in their
constituent subunits contribute to various diseases (Jentsch, 2000). In the nervous system, Kv7
channels play a key role in regulating excitability in many central and peripheral neuronal types,
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and their physiological function depends on their distribution
in specialized subcellular domains such as axon initial segments,
nodes and nerve terminals (Battefeld et al., 2014). Since
M-currents are present at key locations in nociceptive
pathways and their activation by selective compounds exerts
antihyperalgesic actions in several models of pain, the interest
in Kv7 modulation for analgesia has grown in later years
(Rivera-Arconada et al., 2009). In most neurons, M-currents
are produced by Kv7.2-Kv7.3 heteromers or Kv7.2 homomers
(Brown and Passmore, 2009).
Recent studies have shown that Kv7.2 protein levels decrease
in the dorsal root ganglia (DRG) from rats subjected to bone
cancer or partial sciatic nerve ligation (PSNL) contributing to
makeDRGneuronsmore excitable (Rose et al., 2011; Zheng et al.,
2013). In apparent contradiction, we have reported increased
levels of Kv7.2 in the peripheral terminals of axotomized fibers
from mice subjected to saphenous nerve axotomy (Roza et al.,
2011) which may contribute to stabilize the terminals (Roza
and Lopez-Garcia, 2008). At a behavioral level, channel opening
using specific compounds like retigabine reduces hyperalgesia
in animal models of neuropathy (Blackburn-Munro and Jensen,
2003).
These observations raise a number of basic questions that
are presently unanswered. It is unknown whether the decrease
of Kv7.2 expression in the DRG and its accumulation in the
neuroma are concomitant events in a model of neuropathy
involving axotomy. If this was the case, the mechanisms
underlying channel rearrangement should be addressed. Channel
expression in the different compartments of sensory neurons
may depend on processes such as channel synthesis and
degradation, transport and anchoring to the membranes. The
decrease of Kv7.2 channels within the DRG following PSNL has
been attributed to transcriptional repression (Rose et al., 2011),
whereas the causes of accumulation within saphenous neuromas
remain unexplored.
The working hypothesis proposed here is that the anterograde
transport for Kv7.2 channels may be enhanced by axotomy,
therefore contributing to reduce the content of Kv7.2 channels in
cell somata while increasing its presence in terminals. Although
this novel mechanism may coexist with others, we thought that
its relevance could be estimated by blockade of axonal transport.
In order to test this hypothesis, we have used
immunohistochemical techniques and a mouse model of
neuropathy, which involves axotomy of two peripheral branches
of the sciatic nerve (SNI). The expression pattern of Kv7.2
channels has not been studied in this model before. Moreover,
this is the first time that the effects of neuropathy on Kv7.2 levels
is investigated in DRG and neuroma from the same animals.
We demonstrate channel redistribution following spared nerve
injury (SNI) with reduced levels of Kv7.2 expression in DRG and
increased levels in damaged terminals. Our experiments show
that channel redistribution is seriously affected by disruption
of axonal transport with vinblastine (VLB) or colchicine (COL)
at non-neurotoxic doses (Dilley and Bove, 2008). We propose
axonal transport as a mechanism able to modulate Kv7.2 levels
in neuronal compartments following axotomy. This class of
modulation has not been described for any Kv7 channels before.
Finally, we explore the impact of axonal transport on
mechanical sensitivity. VLB and COL treatment had an allodynic
effect similar to that produced by SNI. On the contrary,
when either of these drugs were administered on SNI animals,
allodynia was not developed. These results suggests that axonal
transport has an important role in the structural and functional
changes that follow nerve axotomy.
MATERIALS AND METHODS
Animals
Experiments were performed on adult female CD-1 mice
weighing 25–45 g. Animals were maintained at 22◦C on a 12 h
light/dark cycle with ad libitum access to food and water. All
procedures followed European legislation and were approved by
the Animal Care Committee of the University of Alcalá.
Induction of Neuropathy and Fluoro-Ruby
Application
During all the surgical procedures, the mice underwent deep
anesthesia with 3–4% isoflurane (Laboratorios del Dr. Esteve
SA, Barcelona, Spain) in 100% oxygen. For SNI (Shields et al.,
2003) an incision was made in the skin on the lateral surface
of the thigh, the sciatic terminal branches (sural, common
peroneal and tibial nerves) were exposed and the common
peroneal and the tibial nerves were ligated with 8/0 silk and
sectioned distal to the ligature. The sectioned end was inserted
into an approximately 3 mm long silicone tube (0.45 mm
internal diameter) to prevent lateral innervation of surrounding
tissue. The tube was tied in place with the ligature piece of
silk and the incision was closed with 5/0 sutures. Animals
were then housed and inspected periodically for infections or
abnormal behavior. Tissue from these animals was collected at
two time points in which mechanical allodynia starts to develop
(5 days) and reaches a maximum (15 days; Bourquin et al.,
2006).
In some animals 2 µl of a 5% Fluoro-ruby solution
(Molecular Probes, Eugene, OR, USA; D-1817) were applied
into the proximal stump of the sectioned nerves using a glass
micropipette.
During sham surgery, sciatic nerve branches were exposed
but untouched and Fluoro-ruby solution was applied onto the
common peroneal and tibial nerves.
Blockade of Axonal Transport
VLB (Sigma-Aldrich, St. Louis, MO, USA; V1377) and COL
(Sigma-Aldrich, C9754) were prepared in 0.9% saline and
administered intraperitoneally at a dose of 1.25 and 1 mg/Kg
respectively.
VLB was administered 15 days post-surgery for 4 consecutive
days. In other group of animals VLB or COL were administered
one day before SNI surgery and the following 5 consecutive
days. Twenty-four hours after the last injection, DRG and sciatic
nerves were harvested. Mice without axotomy and treated with
VLB or COL were used as controls.
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VLB and COL are microtubule-destabilizing agents which
block axonal transport (Dziegielewska et al., 1976). Since VLB
and COL bind tubulin in a reversible manner we administered
them daily (Jordan and Wilson, 2004). We used doses proved
to be effective at disrupting microtubules and not lethal when
administered during the treatment period (Stock et al., 1967;
Chang and But, 1986). Direct application of high doses of VLB
or COL onto the nerves causes Wallerian degeneration starting
at the site of application (Coleman, 2005). The concentrations
of VLB and COL in the solutions injected to the animals in
our experiments were 0.13 and 0.25 mM respectively. These
concentrations are considered low and produce neither axonal
degeneration nor effects on impulse conduction when applied
directly onto the sciatic nerves (Dziegielewska et al., 1976;
Fitzgerald et al., 1984; Kashiba et al., 1992; Dilley and Bove,
2008).
Induction of Peripheral Inflammation
Inflammation was induced by unilateral intraplantar injection
of 50 µl of Complete Freund’s Adjuvant (CFA; Sigma-Aldrich,
St. Louis, MO, USA; F5881). Paw edema was quantified by
measuring dorso-plantar paw thickness before and after CFA
injection. L4 DRG were collected 1 and 7 days after injection.
During this time frame mechanical allodynia is strong and
significant (Cobos et al., 2012). Control animals received an
injection of 50 µl of sterile physiological saline.
Tissue Collection and Histochemistry
Mice were anesthetized with urethane and perfused intracardially
with 4% PFA in 0.1 M phosphate buffer (PB). The sciatic nerve as
well as the L4 DRG receiving a large input from the sciatic nerve
were dissected and fixed by immersion in 4% PFA in PB for 1.5
or 1 h respectively.
Tissues were cryoprotected with 30% sucrose in PB,
embedded in 7.5% gelatin/15% sucrose in PB, frozen and
sectioned at 16 µm. In some cases, sciatic nerves were teased.
The sections (or teased nerves) were incubated in blocking
solution, 10% donkey serum in Tris-buffered saline (TBS), for
2 h and permeabilized in 0.5% Triton X-100 in TBS for 10 min.
The samples were then incubated with primary antibodies, that
were diluted in TBS, at room temperature for 18 h. Primary
antibodies were rabbit anti-KCNQ2 (Abcam, Cambrige, UK;
ab22897, 1:500), rabbit anti-PanNav (Chemicon, Billerica, MA,
USA; AB5210, 1:500), goat anti-Peripherin Myelin P2 (PMP2;
Santa Cruz Biotechnology, Inc., Dallas, TX, USA; sc-49304,
1:100) and rabbit anti-active Caspase-3 (Casp3; Abcam; ab2302,
1:100). Sections were washed in 0.2% Tween 20 in TBS and
incubated with Alexa-Fluor 488-conjugated donkey anti-rabbit
secondary antibody (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA, USA; 1:500) at room temperature for 1.5 h.
After washing in TBS, the tissue was counterstained with Dapi
(Sigma-Aldrich; D9542, 0.1 µg/ml) to label the nuclei or with
NeuroTrace Nissl stain (Molecular Probes; N-214, 1:200) to label
the neuron cytoplasm or the axonal terminal axoplasm (Jung
et al., 2012). Sections were mounted in Mowiol and analyzed
with fluorescence microscopy (Olympus BX61, Tokyo, Japan).
Fluoro-ruby dye was detected directly onto sectioned tissue
15 days post-surgery.
For each staining experiment, samples from all experimental
conditions to be compared statistically were processed in parallel
(using the same solutions, in the same environment, and with the
same timing).
Image Analysis
All images were analyzed using Fiji software (Schindelin et al.,
2012). To quantify positively stained cells or endbulbs, to
perform diameter measurements of positively stained cells and
to measure mean fluorescence intensity (MFI) of cells we set
an intensity fluorescence threshold. This threshold value was
calculated as the mean intensity of the background staining in
a negative control with the secondary antibody plus five times its
standard deviation. Thresholds were kept constant for all samples
of each experiment. In DRG samples only neurons with nuclei
were counted. To avoid counting of the same cell, sections were
mounted consecutively into five slides, so that sections on the
same slide were separated by at least 64 µm.
The percentage of positive neurons within the DRG from
each animal was determined from counts of ∼500 neurons.
To quantify the total number of neurons DRG were co-stained
with NeuroTrace Nissl stain that labels neuronal cytoplasm. The
percentages obtained for animals from the same experimental
group were averaged.
MFI was measured in Kv7.2(+) cells. The values obtained
from all the cells in the same population and group were
averaged.
The density of Kv7.2(+) structures within neuroma sections
were determined by counting Kv7(+) structures positive for
NeuroTrace Nissl stain (that also labels the axoplasm of axonal
terminals) on higher magnification images (40× objective) of the
central area of the neuroma.
Results are presented as mean ± standard error of the
mean (SEM). Statistical analyses were performed with IBM
SPSS statistics 22 software. Differences between mean values
were analyzed with unpaired Student t-test with or without the
Welch’s correction as appropriate. Diameter size distributions
of neuron populations were compared by using Kolmogorov-
Smirnov test. Significant difference was accepted for p< 0.05.
Behavioral Testing
Three groups of mice receiving either VLB or SNI or VLB +
SNI treatments were tested for cutaneous mechanical allodynia.
Three equivalent groups for COL were also used. Frequency of
paw withdrawal was measured before and after each procedure
adapting a previously reported method (Bourquin et al., 2006).
Briefly, the sural territory of the hind paw was stimulated
10 times with a calibrated von Frey monofilament of 0.16 g
(Stoelting, Woodvale, IL, USA) and the number of positive paw
withdrawals was assessed. Response frequency was represented
as mean ± SEM and the overall effect of each procedure
was analyzed using a two-way analysis of variance (ANOVA)
followed by a post hoc Tukey’s test. Significant difference was
accepted for p< 0.05.
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RESULTS
Kv7.2 Channel Expression in DRG Under
Control, Neuropathic, and Inflammatory
Conditions
As a positive control for the specificity of anti-Kv7.2 antibody, we
performed immunofluorescence experiments in teased sensory
fibers from naïve sciatic nerves. The labeling produced by the
Kv7.2 antibody was similar to that of PanNav. Both stainings
were flanked by the paranodal marker PMP2 (Supplementary
Figure 1). These results are in agreement with previous reports
about Kv7.2 channel localization (Devaux et al., 2004) indicating
specific Kv7.2 labelling.
Kv7.2 co-localized with NeuroTrace in sections of DRG,
indicating selective expression in neurons, and accounted for
16.6 ± 2% of the DRG neuronal population of naïve adult mice
(Table 1 and Figure 1A). Kv7.2 expressing neurons under naïve
conditions had a diameter distribution almost identical to that of
the general population of neurons of the ganglia (Figure 1E).
Immunofluorescence analysis 15 days post-axotomy revealed
a significant reduction in the percentage of Kv7.2(+) neurons
that decreased by∼65% (Table 1, Figures 1A–D). These changes
were not accompanied by significant alteration of neuronal
density (1201 ± 79 and 1027 ± 81 neurons/mm2 in control
and SNI conditions respectively; n = 6 mice each condition,
t-test, p = 0.08). The percentage of neurons undergoing Casp3
activation was not significantly different between DRG from
control and SNI animals (0% and 0.7± 0.4; n = 3 each condition).
After SNI, no changes in diameter distribution were found for
Kv7.2(+) neurons or the general population of DRG neurons
(Figures 1F,G).
The percentage of Kv7.2(+) neurons 1 and 7 days after CFA
injection were 15.9 ± 0.1% and 15.2 ± 1.1% respectively. These
values were not significantly different from those obtained after
saline injection (18.1 ± 2.5% and 16.3 ± 1.5% 1.7; n = 4 for
1 d experiments and n = 3 for 7 days experiments, t-test; see
Supplementary Figure 2).
Kv7.2 Expression Predominantly
Decreases in the Soma of Injured Neurons
15 Days After Axotomy
To check whether Kv7.2 loss was restricted to damaged neurons,
Fluoro-ruby was applied into the proximal stump of sectioned
nerves at the time of axotomy and immunostainig for Kv7.2 was
performed 15 days post-axotomy. Fluoro-ruby is only taken up
by injured axons and transported to the cell somata (Lozeron
et al., 2004; Supplementary Figure 3). In lumbar DRG from SNI
animals, axotomized and intact cells are intermingled. Therefore
Fluoro-ruby tracing allowed us to differentiate injured (Fluoro-
ruby positive) and uninjured (Fluoro-ruby negative) neurons in
the same DRG.
Fluoro-ruby traced neurons accounted for 20.5 ± 3.8% of
DRG neurons (n = 4) of SNI animals. Kv7.2 staining fell by a
much larger amount in Fluoro-ruby(+) neurons (∼91%) than
in Fluoro-ruby(−) neurons (∼42%; Figures 2A–D and Table 1).
The very few neurons that showed double labeling for Kv7.2 and
Fluoro-ruby had significantly lower levels of Kv7.2 fluorescence
than those un-labeled for Fluoro-ruby, or Kv7.2(+) cells in
control DRG (Figure 2E).
Concomitant Kv7.2 Accumulation in
Neuromatose Peripheral Endings 15 Days
After Axotomy
In order to assess a potential concomitant increase in Kv7.2
expression in peripheral endings of damaged sensory fibers, we
analyzed neuromatose fiber endings from animals that had been
subjected to SNI treatment 15 days before and whose ganglia had
been used for the previous experiment.
In contrast to the ganglia, where injured and intact cells
are intermingled, axotomized and intact fibers are anatomically
separated and can be readily identified in the periphery
(Figure 3A). Whereas the intact sural nerve only showed
normal Kv7.2 nodal staining (Figures 3B–E) we found abnormal
accumulations of Kv7.2 in peroneal and tibial fibers within the
neuroma (Figures 3F–M).
Neuromatose accumulations of Kv7.2 were larger than
those of normal nodes (4.2 ± 0.2 µm vs. 1.7 ± 0.2 µm,
p < 0.0001, compare Figures 3E,I). In addition, neuromatose
accumulations were surrounded by nuclei, probably from
Schwann cells, (Figures 3F–I). These accumulations showed a
complete co-localization with NeuroTrace (Figures 3J–M) which
stains the neuronal cytoplasm as well as terminal axoplasm (Jung
et al., 2012).
These Kv7.2(+) structures were abundant in the distal side of
neuromas (30 ± 4.7 structures/0.1 mm2, n = 3 mice) and barely
preset in the proximal side where fiber organization is better
conserved (Supplementary Figure 4). This pattern of staining was
TABLE 1 | Percentage of Kv7.2(+) DRG neurons in control and SNI animals 15 days post-axotomy: effects of vinblastine.
Control SNI VLB Control VLB SNI
% Kv7.2(+) neurons 16.6 ± 2.0 5.9 ± 0.7∗∗ 27.5 ± 3.5 29.5 ± 1.5 ns
n = 7 n = 6 n = 4 n = 7
% Kv7.2(+) neurons in FR(+) population — 1.3 ± 0.2∗∗ — 25.4 ± 4.4 ns
n = 4 n = 4
% Kv7.2(+) neurons in FR(−) population — 9.5 ± 1.4∗ — 31.2 ± 2.7 ns
n = 4 n = 4
FR, Fluoro-ruby (positive or negative staining); SNI, Spared nerve injury; VLB, Vinblastine treated. “n” stands for number of animals. Asterisk denote significant differences
between control and SNI groups: (∗p < 0.05, ∗∗p < 0.01). No differences were found between VLB Control and VLB SNI groups (ns, not significant).
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FIGURE 1 | Expression of Kv7.2 channel in the dorsal root ganglia (DRG) neurons of control and SNI animals 15 day post-surgery. (A−D) Show cryostat
sections of DRG from control and SNI animals respectively. Sections were immunostained with Kv7.2 antibody and counterstained with NeuroTrace to reveal all
ganglia neurons. Scale bar in (D) applies to all images. (E) Graph showing the diameter distribution of neurons positive for Kv7.2 or NeuroTrace as indicated by color
code. Graphs in (F,G) show diameter distribution of neurons labeled by Kv7.2 and NeuroTrace in control and SNI conditions. For each trace, the sum of percentages
across all diameter intervals is 100%. The diameter was measured in at least 100 positively stained neurons in each DRG. Data points represent mean percentage
values from three different ganglia. There were no significant differences between pairs of distributions as compared with the Kolmogorov-Smirnov test. The obtained
p value is shown in the upper right corner of each graph.
not present in the intact sural nerve of experimental animals
(Figures 3B–E), or in the sciatic branches from naïve animals
(not shown).
FIGURE 2 | Expression of Kv7.2 in Fluoro-ruby(+) DRG neurons 15 day
post-surgery. (A) Shows a representative section from the DRG obtained
from an animal in which axotomized fibers (SNI) were labeled with Fluoro-ruby.
(B) Shows same slide stained for Kv7.2. (C) is a merge of (A,B) in which
arrows indicate the few neurons co-localizing Kv7.2 and Fluoro-ruby.
(D) Shows Kv7.2 counterstained with NeuroTrace. (E) Graph shows mean
fluorescence intensity (MFI) for Kv7.2 in DRG neurons from control and SNI
animals. Note that MFI was significantly lower in Fluoro-ruby(+) from SNI
animals compared to neurons in control DRG (n = 3; t-test, ∗p = 0.003) or
Fluoro-ruby(-) neurons in SNI DRG (n = 3; t-test, #p = 0.002). AU, arbitrary
units. ∗ or #p < 0.05.
Role of Axonal Transport in the
Redistribution of Kv7.2 After Neuroma
formation
A group of animals with a developed neuroma (15 days after
axotomy) and a control non-axotomized group were treated with
VLB to block axonal transport. Following VLB treatment, Kv7.2
labeling was detected within the axons leaving the DRG in both
control and axotomized animals suggesting an effective blockade
of the transport (Figure 4C inset).
Quantitative analysis as shown in Table 1 indicates that VLB
treatment eliminates the difference in DRG labeling of Kv7.2
produced by axotomy, such that after VLB the percentage of
neurons labeled for Kv7.2 in injured animals was very similar to
that of uninjured animals (Figures 4A–D and Table 1).
VLB produced a ∼1.7 fold increase in the percentage of
Kv7.2(+) neurons in non-axotomized animals. This small but
significant increase suggests a physiological transport of the
channel (t-test, p = 0.02, Table 1). In SNI animals, VLB produced
a ∼5 fold increase in the percentage of Kv7(+) neurons (t-test,
p < 0.0001, Table 1). This higher increase in the Kv7.2(+)
neurons suggests an enhanced transport after axotomy.
The effects of VLB on Kv7.2 expression were also examined
in experiments with Fluoro-ruby labeling of axotomized fibers.
The percentage of Fluoro-ruby(+) neurons in these experiments
was 22.8 ± 2.5% (n = 4; Figure 4E). The transport of Fluoro-
ruby from the sectioned nerve end to the soma within the DRG
was not affected by VLB, since it was administered 15 days
post-axotomy, time at which Fluoro-ruby had reached the DRG
already.
Following VLB treatment, Kv7.2 was present in 25.4 ±
4.4% of Fluoro-ruby(+) neurons, which represents a ∼20
fold increase over injured animals without VLB. In addition,
Kv7.2 staining was present in 31.21 ± 2.7% of Fluoro-ruby(-)
neurons of the ganglia, a percentage ∼4 fold higher than that
observed in the corresponding control. After VBL treatment the
percentage of Kv7(+) neurons was similar for Fluoro-ruby(+)
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 December 2015 | Volume 9 | Article 470
Cisneros et al. Kv7.2 Channel and Axonal Transport
FIGURE 3 | Expression of Kv7.2 in neuromatose fiber endings 15 day
post-axotomy. (A) Sciatic nerve branches from SNI mice were sectioned and
stained with Dapi. Injured fibers from common peroneal and tibial nerves
(forming the neuroma) and un-injured fibers from sural nerve (delineated by
dashed lines) are anatomically separated and can be readily identified. (B–E)
images correspond to a magnification of the un-injured sural nerve. Sciatic
nerves from SNI mice were sectioned, immunostained with Kv7.2 antibody
and counterstained with Dapi to label cell nuclei. In sural intact branches
labeling was found in normal nodes, indicated by white arrows in (B–D), and
was not associated with cell nuclei (C–E). (F–M) images correspond to a
magnification of injured common peroneal and tibial nerves. (F–I) Injured fibers
show Kv7.2 in large structures which were surrounded by nuclei. (J–M) Show
sciatic nerve sections from SNI mice immunostained with Kv7.2 and
counterstained with NeuroTrace showing that Kv7.2(+) accumulations were
localized in terminal axoplasm. Scale bar in (M) applies to (E,I) images. Scale
bar in (L) applies to the rest of images.
and Fluoro-ruby(−) populations (t-test, p = 0.3, Figures 4C–F
and Table 1). Results are summarized in Venn diagrams of
Figure 4G.
Under the present conditions, VLB treatment did not change
the expression pattern of Kv7.2 in the periphery. Channel
accumulations co-localizing with NeuroTrace at neuromatose
endings were observed at the same density after VLB treatment
(18 ± 2.5 structures/0.1 mm2, n = 3 mice vs. 30 ± 4.7
FIGURE 4 | Expression of Kv7.2 in the DRG from mice treated with
Vinblastine (VLB) since day 15 post-surgery. Sections of DRG from
VLB-treated control (A,B) and VLB-treated SNI mice (C–F) were
immunostained with Kv7.2 antibody and counterstained with NeuroTrace. The
percentage of Kv7.2(+) neurons was similar in both samples. Inset in
(C) shows Kv7.2 labeling in axons of DRG neurons (yellow arrow), suggesting
an effective blockade of axonal transport. (E) Shows DRG neurons traced with
Fluoro-ruby. The merge of (C,E) is shown in (F) where a large proportion of
Fluoro-ruby(+) and Kv7.2(+) neurons can be appreciated after VLB treatment.
Scale bar in (F) applies to all images. (G) Venn diagrams summarizing the
percentage of Kv7.2(+) neurons in the DRG from non-axotomized or SNI mice
that were untreated or treated with VLB. FR, Fluoro-ruby positive neurons.
structures/0.1 mm2 in un-treated 15 days SNI, n = 3 mice;
p = 0.10). In the sciatic nerve from non-axotomized animals and
in the uninjured sural nerve from SNI mice, Kv7.2 displayed the
normal nodal staining.
Role of Axonal Transport in the
Redistribution of Kv7.2 in Sensory Neurons
during neuroma development
We asked whether axotomy produces a short-term Kv7.2
redistribution in sensory neurons. Immunofluorescence
analysis 5 days post-surgery revealed a significant reduction
in the percentage of Kv7.2(+) neurons in the DRG from
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SNI animals (∼60%, Table 2) and the presence of Kv7.2
accumulations in the injured tibial and common peroneal
fibers within the neuroma (Figure 5). These structures
co-localized with NeuroTrace and where not found in the
intact sural nerve, which only showed normal nodes (not
shown). These results are similar to those obtained 15 days
post-surgery.
VBL was applied to a group of animals for 6 days starting 1day
pre-axotomy and to a control group without surgery for the same
time lapse. To determine whether VLB produced neurotoxicity
we analyzed Casp3 activation in the sensory neurons of mice
receiving VLB, SNI oVLB + SNI. Active Casp3 was not detectable
in the sensory neurons of any group (n = 3 mice each group;
Supplementary Figure 5).
Under VLB treatment, the percentage of Kv7.2(+) neurons
in the DRG was not significantly different between SNI and
control animals. VLB produced a ∼5 fold increase in the
percentage of Kv7(+) neurons 5 days post-axotomy (t-test,
p = 0.002, Table 2). This result is similar to that observed
whenVLBwas administered from day 15 post-axotomy onwards.
In the VLB-treated control DRG the percentage of Kv7.2(+)
neurons increased∼2.4 fold (t-test, p = 0.05, Table 2), indicating
again that axonal transport is enhanced following axotomy
(Figures 5A–H).
VLB administration before axotomy changed the expression
pattern of Kv7.2 in the periphery. Kv7.2 accumulations were
virtually absent within the neuromas from VLB-treated animals,
when compared to those from VLB-untreated SNI mice (6± 0.2
and 28 ± 0.7 structures/0.1 mm2 respectively, n = 3 mice each
condition; t-test, p = 0.001; Figures 5I–M).
To confirm the role of axonal transport in Kv7.2
redistribution following axotomy we analyzed the effect of
another transport blocker drug, COL. COL was administered
following the same time course described above for VLB and
DRG and neuromas were analyzed by immunofluorescence.
COL treatment abolished the difference in the percentage of
Kv7.2(+) neurons between control and SNI animals (Table 2).
COL treatment did not changed the percentage of Kv7.2(+)
neurons in control DRG (Table 2; t-test, p = 0.4).
In the periphery, the density of Kv7.2(+) structures
significantly decreased within the neuromas from animals
treated with COL, when compared with neuromas from
un-treated animals (4.2 ± 0.4 and 28 ± 0.7 structures/0.1 mm2
respectively, n = 3 mice each condition; t-test, p = 0.002,
Supplementary Figure 6).
Axonal Transport and Nociceptive
Behaviors
In order to obtain clues about the possible functional meaning
of channel transport and subsequent rearrangements, we tested
sensitivity to low threshold mechanical stimuli in three groups of
animals receiving either VLB or SNI or VLB + SNI treatments.
Baseline values were obtained for all groups before any other
procedures at day 0. Immediately afterwards still in day 0, VLB
was administered to animals of VLB and VLB + SNI groups
which received daily doses until the end of the experiment.
At day 1, axotomy was performed in animals of the SNI and
VLB + SNI groups. Mechanical responses were tested again at
day 6.
The results of this experiment are shown in Figure 6A.
As expected, allodynic effects were obvious in the SNI group.
Animals receiving VLB alone did develop allodynia to a similar
degree than axotomized animals. However, VLB administered
to axotomized animals produced a complete reversion of
allodynia.
To confirm that behavioral changes observed after VLB
treatment were due to axonal transport blockade, we measured
mechanical response in animals receiving COL, SNI and
COL + SNI in the same conditions described above. COL alone
produced an increase in mechanical responses similar to that
observed in SNI animals. On the contrary, COL treatment had
an analgesic effect in SNI animals, although milder than that
produced by VLB (Figure 6B).
DISCUSSION
Consistent with previous reports, we find that Kv7.2 is expressed
in approximately 16% of the neuronal population of mice DRG.
Under our conditions, analysis of diameter distribution indicates
that Kv7.2 is present in sensory neurons of all sizes and no
enrichment in small or large neurons was detected (Passmore
et al., 2003; Rose et al., 2011; King and Scherer, 2012; Zheng et al.,
2013).
The present results show a significant decrease of Kv7.2(+)
neurons in the DRG of animals that had undergone an SNI
procedure. The decrease is not due to neuronal loss, since
TABLE 2 | Percentage of Kv7.2(+) DRG neurons in control and SNI animals 5 days post-axotomy: effects of vinblastine and colchicine.
Control SNI VLB Control VLB SNI
% Kv7.2(+) neurons 13.9 ± 1.5 5.5 ± 0.6∗ 33.1 ± 3.4 29.2 ± 1.7 ns
n = 3 n = 3 n = 3 n = 3
Control SNI COL Control COL SNI
% Kv7.2(+) neurons 16.2 ± 2.0 4.5 ± 1.4∗∗ 14.0 ± 0.2 13.7 ± 1.4 ns
n = 3 n = 3 n = 3 n = 3
COL, Colchicine treated; SNI, Spared nerve injury; VLB, Vinblastine treated. “n” stands for number of animals. Asterisk denote significant differences between control and
SNI groups: (∗p < 0.05, ∗∗p < 0.01). No differences were found between Control treated with VLB and COL and corresponding SNI groups (ns, not significant).
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FIGURE 5 | Expression of Kv7.2 in the DRG and neuromas from mice
treated with VLB during neuroma development. (A–H) Show images of
representative ganglia stained with Kv7.2 and counterstained with NeuroTrace
from each experimental condition as labeled. Kv7.2 labelled neurons decrease
within the DRG 5 days after axotomy. VLB administration before and during
neuroma development prevents the reduction of Kv7.2 labeled neurons. (I)
Shows a 5 day neuroma in which Kv7.2 accumulations are evident. (K–M) are
a magnification of (I) to show that Kv7.2 structures are co-labeled with
NeuroTrace. (J) Show a 5 day neuroma from an animal treated with VLB
before and during neuroma formation. Note that Kv7.2(+) structures are
virtually absent. Scale bar in (A) applies to (B–J) images. Scale bar in (K)
applies to (L,M) images.
neuronal density remains unchanged and the percentage of active
Casp3 is anecdotal. Additionally, the decrease is not associated
to small or large cells, but rather it distributes uniformly with
neuronal diameter. These results are consistent with previous
FIGURE 6 | Effect of blockade of axonal transport on mechanical
sensitivity. Graphs show behavioral effects of VLB (A) and Colchicine (COL)
(B) on control and after 6 days of drug treatment. Bars represent percentage
of withdrawals to a set of 10 stimuli applied with a Von Fray filament (0.16 g) to
the plantar surface of the hind paw (n = 4 for VLB and n = 5 for COL, ANOVA
with post hoc Tukey’s test; ∗denote differences with corresponding baseline
values; #denote differences between VLB- or COL-treated SNI animals and
other conditions at day 6 of treatment).
studies showing a decrease of Kv7.2 levels in the DRG of rats
subjected to bone cancer and peripheral sciatic nerve ligation
(Rose et al., 2011; Zheng et al., 2013) indicating that the Kv7.2
decrease in the DRG is a general mechanism triggered by
peripheral nerve damage and shared by different species. Here we
show that other pain-producing conditions, such as peripheral
inflammation, do not produce any change in somatic levels of
Kv7.2 channels.
The present results show that most ganglion cells decreasing
their levels of Kv7.2 expression correspond to axotomized
fibers. According to our results, Kv7.2 labeling is virtually lost
in fibers marked with Fluoro-ruby at the time of the lesion
(∼91% reduction). However, uninjured neurons within the DRG
of SNI treated animals appear to contribute towards Kv7.2
decrease, although to a lesser extent (∼42% reduction). In
this regard, it has to be considered that whereas axotomized
neurons were unequivocally identified by Fluoro-ruby tracing,
some axotomized neurons perhaps did not incorporate Fluoro-
ruby. A study using ATF3 to mark injured cells has shown
that common peroneal and tibial nerves account for 35% of
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fibers contributing to the L4 ganglion (Laedermann et al., 2014),
whereas here we report only 20% of neurons with Fluoro-
ruby. Consequently, the contribution of intact neurons could
have been overestimated. Extrapolating our results to a scenario
where 35% of DRG neurons were injured, we could still find
a percentage of apparently intact neurons with reduced Kv7.2
expression. In this context, we cannot propose this phenomenon
to affect selectively to damaged neurons. However, it is possible
thatmodulation of Kv7.2 in intact neurons is due to their capacity
to respond to soluble molecules secreted by neighboring injured
neurons (Shinder et al., 1999).
Concomitant to the decrease of Kv7.2 levels in the DRG, an
abnormal accumulation occurred in axotomized peroneal and
tibial fibers within the neuroma, while the intact sural nerve
displayed the normal nodal Kv7.2 staining (Devaux et al., 2004;
Roza et al., 2011). Previously, we reported the accumulation of
Kv7.2 in abnormal patterns at nodes of axotomized saphenous
fibers (Roza et al., 2011). In addition to these abnormal
patterns, here we describe for the first time the accumulation
of the channel in neural structures surrounded by nuclei,
which according to previous descriptions could be neuromatose
endbulbs, sites whichmay work as ectopic sensors and generators
of spontaneous activity (Fried et al., 1991; Devor et al., 1993).
Nerve injury, then, triggers a process of redistribution of Kv7.2
channels that predominantly affects to injured neurons.
The major finding of the present work is to show
the contribution of axonal transport to Kv7.2 channel
rearrangement. To check this point we have treated naïve and
SNI mice with VLB or COL. These two agents effectively block
axoplasmic anterograde and retrograde transport (Dziegielewska
et al., 1976). On the basis of available data, we have used
concentrations that do not produce axonal degeneration neither
effects on impulse conduction that are seen when high doses
of the blockers are directly applied onto the sciatic nerves
(Dziegielewska et al., 1976; Fitzgerald et al., 1984; Kashiba et al.,
1992; Dilley and Bove, 2008). Moreover, we have not detected
activation of Casp3 within the DRG of control or SNI animals
treated with VLB. All this indicates that the effects of VLB and
COL are due to their axon transport blocking properties.
In control animals, administration of VLB increased the
percentage of Kv7.2(+) neurons by ∼1.7 fold. This increase
produced by VLB may reflect basal axonal transport working
under physiological conditions. However, administration of COL
did not affect channel levels in control animals (Tables 1, 2)
suggesting that either COL is less effective than VLB or that
VLBmay have some nonspecific effects. Regardless of differences
between the compounds, both of them were able to dampen the
effects of SNI on Kv7.2 loss in DRG when applied after neuroma
formation or during its development.
When VLB was applied 15 days post-SNI, the percentage
of Kv7.2(+) neurons increased up to ∼20 fold within the
population of Fluoro-ruby(+) neurons from SNI animals
indicating that axotomized fibers have an enhanced transport.
Most importantly, the treatment of neuropathic mice with
VLB restored the levels of Kv7.2 injured neurons within the
DRG (Table 1). On the other hand, accumulations of Kv7.2
within endbulbs were retained. In this set of experiments, VLB
was administered to SNI animals once neuromas and Kv7.2
accumulations had already formed. As VLB blocks retrograde
transport as well, we believe that under these conditions the
channel was retained at axonal terminals. In contrast, peripheral
accumulations of Kv7.2 were prevented by VLB and COL when
these were applied prior and during neuroma development.
Interestingly, blockers of axonal transport applied during the
development of the neuroma did reverse the decrease of Kv7.2
expression in DRG as well. Together these results suggest that
axonal transport may be a major mechanism operating after
axotomy to produce channel distribution rearrangements in
sensory neurons.
The levels of a protein in a particular cell compartment at a
fixed time is the result of the production (rate of transcription
and translation), transport to the target compartment (by
molecular motors as kinesins), fixation to target compartments
through linker proteins (as Ankyrin-G in the case of Kv7.2) and
recycling/degradation processes. Therefore, Kv7.2 expression
pattern in axotomized sensory neurons could be mediated by
different mechanism. In a model of neuropathy involving nerve
ligation (PSNL) but not axotomy, Kv7.2 decrease within the
DRG has been attributed to transcriptional repression (Rose
et al., 2011). Under the present experimental conditions and in
our hands, the results obtained are not consistent with a major
role for this mechanism suggesting the implication of different
mechanisms under different lesion types.
There is evidence for a role of axonal transport in the
distribution of other ionic channels after injury. Nav1.8 channel
display a similar redistribution after chronic constriction injury,
diminishing in the DRG and accumulating along the sciatic nerve
(Novakovic et al., 1998). In models of peripheral inflammation,
accumulation of Nav1.8 in the sciatic nerve depends on the
interaction with the motor protein KIF5B (Su et al., 2013). The
molecules that promote Kv7.2 transport to the periphery are
unknown, but KIF5 proteins are possible candidates since they
have been shown to interact with potassium channels (Xu et al.,
2010).
Redistribution of proteins such as Nav or Kv channels, as
a consequence of changes in axonal transport might be one
important factor conditioning the development of pain signs
following peripheral nerve damage. Here we show that the overall
blockade of axonal transport with VLB or COL has different
effects on axotomized and control animals.The present data
show that VLB or COL applied to control non-axotomized
animals produces mechanical allodynia similar to that produced
by SNI treatment. Previous data showed that local application
of VLB and COL to the sciatic nerve produces an increase in
mechanical sensitivity probably caused by ectopic accumulation
of mechanically sensitive ion channels, nerve growth factors or
voltage-gated channels proximal to the site of transport blockade
(Dilley and Bove, 2008; Dilley et al., 2013).
VLB and COL administered before and during neuroma
development to our SNI animals exerted anti-allodynic effects.
In line with this, it has been shown that VLB reduces ectopic
discharges in injured nerves (Devor andGovrin Lippmann, 1983)
suggesting that the components mediating mechanical sensivity
need to be transported following axotomy. In addition, VLB and
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COL have been reported to exert anti-inflammatory effects due
to their anti-proliferative actions (Dilley and Bove, 2008). This
could have contributed towards the anti-allodinic effet of the
blockers.
In the absence of a more specific tool to block Kv7 channel
transport only, these experiments show a clear contribution of
axonal transport to the estructural and functional changes that
occur in sensory afferents after injury.
The specific pathophysiological significance of Kv7.2 decrease
in the DRG and accumulation in the injured fibers is difficult
to anticipate. Due to the properties of Kv7 channels, increased
expression should exert stabilizing effects on membranes
hyperpolarizing the resting potential and decreasing excitability.
This should increase the threshold for the firing of action
potentials initiated by Nav channels (Battefeld et al., 2014).
Experimental evidence obtained in peripheral damaged fibers
do confirm this interpretation (Roza and Lopez-Garcia, 2008).
Therefore we interpret that the increased expression of Kv7.2 in
neuromas may work as a homeostatic mechanism compensating,
at least in part, for an incresed excitability caused by
accumulation of Nav channels, transductor proteins and growth
factors. The overexpression of Kv7 channels in neuromas may
decrease their responsiveness to natural stimuli and the chances
to originating ectopic spontaneous discharges.
In contrast, a decreased expression of Kv7.2 channels should
cause the opposite effects, that is depolarization and increased
excitability. In agreement, experimental data obtained by King
et al. (2014) show that a selective decreased expression of
Kv7.2 renders DRG neurons more excitable. This in turn may
contribute towards pain symptoms caused by neuropathy such
as spontaneous pain.
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